A look at previous situations that may return to the spotlight
Vivendi is known for headline-grabbing M&A, rarely for its organic growth. We think this is about to change: we see
Vivendi delivering 5% organic growth for the first time in a decade in 2017–18, shifting the story from value to growth
- with the potential for a re-rating.
Achieving this growth requires a fix for French pay-TV. It also needs growth from music streaming to more than compensate for the decline in the legacy formats.
Can this happen? The findings of our extensive consumer survey, STAMP, and new work on music industry trends suggest it is possible.
Sentiment on Vivendi is bearish, reflecting Canal’s struggles and confusing capital allocation. Yet investors will cheer if growth surprises. We turn Outperform.
What are the key themes? What new work have we done?
1) Will Streaming grow 25% or 35% in 2017–18?
The difference is 300bp+ on organic growth at Music and almost 200bp for the group. We think the answer is 35%. We have analysed the potential of subscription streaming, combining the results
of our unique STAMP survey (10k participants, c80% of the music market, notably to assess the take-up of Spotify and Apple Music) with a new tracking of streaming subs. We are bullish. We see Streaming growing c35% in 2017–18 and expect organic growth at Music to accelerate to 5–7% in 2017–19.
2) Can Canal’s French pay-TV be turned around? We expect signs of recovery in H1 17, which could be a major catalyst.
Through STAMP, we asked Canal subscribers how they feel about their subscriptions. It is early days, but we see reasons for the decline in subs to ease in 2017. At the same time, the broader Canal group will benefit from new wholesale offers
and from strong growth in Africa and Content. France will remain tough but Canal group should return to growth.
What to Watch at Thursday’s ECB Meeting
Economists say it’s probably too soon for the ECB to change course on its QE program
It’s two years since the European Central Bank launched its giant bond-purchase program, known as quantitative easing, and its efforts finally appear to be bearing fruit. Inflation in the 19-nation eurozone has suddenly jumped to 2%, slightly above the ECB’s target, after hovering around zero for years. That has prompted calls for a policy reversal from Frankfurt, particularly in inflation-averse Germany. Investors will listen closely to ECB President Mario Draghi’s news conference on Thursday for signs for the road ahead.
What is the ECB expected to do this week?
Stand its ground. The ECB only recently expanded its QE program by a half-trillion euros, and economists say it’s probably too soon to change course. The recent jump in inflation is mainly due to higher energy prices, and that effect is likely to fade later in the year. Crucially, the region faces a tense political calendar over the coming months, and the ECB has indicated it wants to keep a steady hand on the economic tiller. “Another few quarters of macroeconomic data and knowing the outcome of the French elections are probably necessary for the ECB to start to change its tone,” said Vincent Juvyns, global market strategist at J.P. Morgan Asset Management.
How strong is the eurozone economy?
It’s improving. Unemployment is down, inflation is up and the bloc’s growth rate is currently outpacing that of other major advanced economies, according to financial-data firm IHS Markit. The ECB’s new economic forecasts, to be published on Thursday, are expected to show upward revisions to inflation for this year and next. Still, average data mask wide differences across the region: While northern European economies are accelerating, some in the south are struggling with weak productivity growth and a mountain of nonperforming loans.
When is the time to taper QE?
Within the central bank, policy makers are divided over whether the current level of stimulus is too strong for a recovering economy. Some top officials have suggested it may soon be time to start tapering, or winding down, the QE program. But investors are already tense ahead of elections in the Netherlands and France, which could see strong gains by anti-euro parties such as France’s National Front. The spread between yields on safe German bunds and government bonds in France and Germany has been widening for months. Against that backdrop, any public discussion of tapering looks premature.
What else could the ECB do?
While policy makers might shy away from any major policy changes, they might decide to send investors a signal that the days of ever-greater monetary stimulus are over. To do so, they could tweak the language of their policy statement to indicate that the risks to economic growth have diminished, or drop a commitment to accelerate QE if needed. The pace of the ECB’s bond purchases is set to fall from €80 billion ($84.52 billion) a month to €60 billion, starting in April.
What about interest rates?
The ECB has carefully left open the option of a fresh rate cut, ever since investors took fright a year ago at Mr. Draghi’s suggestion that rates had reached bottom. With inflation now above target, however, that pledge looks outdated. Yves Mersch, who sits on the ECB’s six-member executive board, suggested last month it should be dropped for the sake of the bank’s credibility. Still, other ECB officials have warned against even that small change. “The ECB wants to approach any policy shift with great caution,” said Marco Valli, an economist with UniCredit in Milan.
Scotland could hold independence vote in 'autumn 2018': Sturgeon
Scotland could hold an independence referendum in autumn 2018, just months before the United Kingdom is due to leave the European Union, Scottish First Minister Nicola Sturgeon said, the BBC reported.
The threat of a second Scottish independence vote further complicates Prime Minister Theresa May's negotiations with the other 27 members of the European Union over the United Kingdom's divorce terms.
Sturgeon said autumn 2018 would be a "common sense time" for Scotland to hold another independence referendum, once there is some outline of a deal to exit the European Union.
"Within that window, of when the outline of a UK deal becomes clear and the UK exiting the EU, I think would be common sense time for Scotland to have that choice, if that is the road we choose to go down," Sturgeon, who heads Edinburgh's pro-independence devolved government, told the BBC.
No decision has yet been taken on a date for a vote, she added. Under current constitutional conventions, a second independence vote would have to be approved by the United Kingdom's government in London.
The results of the June 23 Brexit referendum called the future of the United Kingdom into question because England and Wales voted to leave but Scotland and Northern Ireland voted to stay.
Sturgeon has repeatedly warned that the Brexit plans of the government in London could force Scots to call another vote on the grounds that circumstances had changed since 2014 when Scots voted 55-45 to stay in the United Kingdom.
Akzo Nobel Rejects $22 Billion Offer From PPG
Dutch chemicals maker says offer substantially undervalues the company
Dutch paints and chemicals maker Akzo Nobel NV said Thursday it has rejected an unsolicited €20.9 billion ($22.1 billion) offer from U.S. peer PPG Industries Inc.
Amsterdam-based Akzo said PPG made an offer of €54 in cash and 0.3 PPG shares for each Akzo share, corresponding to a value of €83 a share.
Akzo, which counts Dulux, Sikkens, Interpon and Eka among its brands, said PPG’s proposal “substantially” undervalues the company and isn’t in the interest of its shareholders.
The company now plans to review options for the separation of its specialty-chemicals business, which generated revenue in 2016 of €4.8 billion.
Akzo said it would consider various alternative ownership structures for the specialty-chemicals business, including a new independent listed entity.
At close of business Wednesday, Akzo had a market capitalization of $17.12 billion, while PPG’s was $27.47 billion.
Dow -0.33% S&P -0.23% Nasdaq +0.06% Russell -0,64%
US Market closed lower, pushed by Crude. WTI$ closed at $50.40/bbl -5.3% after the EIA inventory report that show a much higher build than the consensus (8.2mil vs 2mil estimates)Energy closed the day at the bottom of the leaderboard with a loss of 2.5%. The rate-sensitive utilities (-1.5%) and real estate (-1.5%) groups also finished solidly lower amid an increase in interest rates following a better than expected ADP National Employment Report, which clobbered consensus estimates; the reading showed that a whopping 298,000 private-sector jobs were added in February (consensus 180,000).
Following today's economic data, the CME Fed Watch Tool now assigns an implied probability of 90.8% to a March rate hike, up from 81.9% on Tuesday. Furthermore, the market expects to see another rate hike by the September meeting. At the top of the day's sector standings were the health care (+0.3%) and consumer discretionary (+0.3%) sectors with the latter space receiving a boost from retailers. The technology (+0.1%), financials (unch), and materials (+0.1%) sectors finished near their flat lines while the telecom services (-0.4%), consumer staples (-0.3%), and industrials (-0.4%) groups finished with modest losses. US After Hours ELF +16%, SMTC +7% following earnings/guidance, APRI +34.2% on asset sale news/NDA update... TLRD -29%, SPPI -10%, WATT -7% following earnings/guidance. Asia indices are largely lower, tracking the 3rd consecutive down day in the S&P500. Nikkei225 is among the few gainers, helped by weaker JPY in the wake of a blowout ADP jobs report that sent US Treasury yields and USD higher across the board. In FX, USD/JPY approached 114.60 in Asia session, just shy of US hours high, while AUD/USD fell to 7-week lows near 0.75. NZD/USD was also sold off on USD strength, falling below $0.79 for the first time since early Jan. Feb PPI rose for the 6th straight month and to its highest level since Sept 2008 thanks to recent jump in commodity prices. Conversely, CPI fell m/m for the first time in 4 months, and y/y figure hit a 2-year low after a near-3-yr high last month. In Japan, Toshiba was hit especially hard on press speculation of expanded loss related to nuclear ops as well as rising challenges of meeting the deadline for releasing already delayed Q3 earnings report.
Nikkei +0.34% Hang Seng -1.31% CSI -0.82% Shanghai -0.88%
Eur$ 1.0537 CNH 6.9167 CNY 6.9171 JPY 114.47 GBP 1.2159 CHF 1.0154 RUB 58.8501 WTI$ 50.53 +0.52%
S&P -0.01% EuroStoxx -0.32% Dax -0.26% FTSE -0.46% SMI -0.22%
Macro :
- Draghi’s Forward Planning Keeps Bar High for Stimulus Change
- Oil Slumps to Lowest This Year as Traders Focus on Record Supply
- Bill Gross’s Bond Bear Market Looms as 10-Year Yield Nears 2.6%
Keep an eye on :
- ABI BB : AB InBev Co-Controlling Holder Patrinvest Buys EU50.7m of Stock
- AC FP : Accor Sells 62 Hotels to SNI, to Own Majority of HotelF1 Assets
- AKZA NA : PPG Industries Said to Explore Potential Deal With Akzo Nobel, Chemical Peers Jump as PPG Said to Explore Deal With Akzo Nobel
- AKZA NA : PPG Deal Likely to See Heavy Anti-Trust Scrutiny: Seaport Global
--> Akzo Nobel Rejects Unsolicited Indicative Proposal From PPG
- ATC NA : Altice 4Q Adj. Ebitda Jumps 16%; Co. Sees Profit Growth in 2017
- ALT FP : Altran Technologies Sees Profitable Growth in 2017
- AMG NA : AMG 4Q Revenue Rises 8% to $238m, Ebitda More Than Triples
- SPR GY : Axel Springer 2016 Organic Revenue Growth 4.1%; Raises Dividend
- BOSS GY : Hugo Boss Profit May Rise This Year as Turnaround Takes Shape
- BPOST BB : Bpost Profit, Dividend Forecast Trails Ests.; 4Q Ebit in Line
- BT/A LN : BT to Name Rio Tinto’s Jan Du Plessis as Chairman: FT
- CA FP : Carrefour 2016 Recurring Op. Income EU2.35B; Est. EU2.39B
- CSGN VX : HSBC Sells More U.S. Mortgages to Credit Suisse for $3.4b
- DBK GY : Deutsche Bank’s Qatar, China Investors Said to Back Rights Offer
- DBK GY : Deutsche Bank Will Struggle to Reach ROTE Above 5%: Berenberg
- ELIOR FP : Elior Largest Shareholders May Vote Against CEO Pay: L’Agefi
- ENGI FP : Engie to Take Part in Suez’s Capital Increase for About EU240m
- EOAN GY : EON to Post 2016 Net Loss of More Than EU12.4b: Handelsblatt
- HSBA LN : HSBC Sells More U.S. Mortgages to Credit Suisse for $3.4b
- LIN GY : Linde 4Q Profit Misses, Says Praxair Deal on Schedule
- MMB FP : Lagardere Expects ’Good Year’ in 2017, CEO Says
- MOR GY : MorphoSys FY Rev. Misses Est., Cash Position EU359.5m at yr end
- PLT IM : Lactalis’ Sofil Raises Offer Price on Parmalat to EU3/Share
- SCAB SS : Carnegie Raises SCA Stake, Wants to Split Company in Three: DI
- SEV FP : Suez and CDPQ to Buy GE Water for EU3.2b Enterprise Value
- SEV FP : Engie to Take Part in Suez’s Capital Increase for About EU240m
- SFR FP : SFR FY Ebitda Slips 0.6%; Co. Sees Revenue Stabilizing in 2017
- SYNN VX : SYT/ChemChina Mofcom Review Said to See Little Opposition: PaRR
- TRE SM : Tecnicas Reunidas Raised to Neutral at Credit Suisse, PT EU34
- UN01 GY : Uniper Forecast 2017 Adj. Ebit to Fall to EU0.9b-EU1.2b, Uniper Hedged >80% of 2018 Sweden Outright Power at EU21-25/MWh
- LANS NA : Van Lanschot Client Assets Rise 10%, Dividend More Than Doubles
>>> Up
*Admiral Raised to Overweight at JPMorgan, PT 2100p
*Air France-KLM Raised to Buy at SocGen, PT EU9
*CaixaBank Raised to Buy at UBS, PT EU3.95
*Cobham Raised to Buy at UBS, PT 155p
*DSM Raised to Neutral at JPMorgan, PT EU60
*Ericsson Raised to Buy at Goldman
*IAG Raised to Buy at Liberum, PT 700p
*Lagardere Raised to Equal-Weight at Barclays
*Proximus Raised to Outperform at Macquarie, PT EU30
*Sopra Steria Group Raised to Buy at AlphaValue
*Telefonica Raised to Buy at Deutsche Bank, PT EU11.40
*Vivendi Raised to Outperform at Exane, PT EU21
>>> Down
*Deutsche Telekom Cut to Underperform at Macquarie, PT EU14
*EDF Cut to Sell at AlphaValue
*Ei Towers Cut to Neutral at Macquarie, PT EU50
*Kinepolis Group Cut to Hold at Berenberg
*Melia Hotels International Cut to Reduce at Intermoney Valores
*Melrose Industries Raised to Buy at Liberum
*Vodafone Cut to Underperform at Macquarie, PT GBP1.70
>>> Initiation
*Amgen Rated New Neutral at UBS, PT $185
*Essilor Rated New Overweight at Barclays, PT EU130
*Gilead Rated New Neutral at UBS, PT $72
*Glaxo Rated New Reduce at Kepler Cheuvreux, PT 1500p
*Incyte Rated New Neutral at UBS, PT $140
*Itron Rated New Market Outperform at JMP, PT $75
*Novartis Rated New Buy at Liberum, PT CHF85
*Regeneron Rated New Buy at UBS, PT $435
*Roche Rated New Hold at Liberum, PT CHF274
*Sanofi Rated New Hold at Liberum, PT EU86